Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Westermann

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastomaMarc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Cancer Letters|December 20, 2015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastomaShile Zhang, Jun S Wei, Samuel Q Li, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Scientific Reports|March 2, 2013
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interactionMarianeve Carotenuto, Emilia Pedone, Donatella Diana, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastomaMarc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Cancer Letters|December 20, 2015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastomaShile Zhang, Jun S Wei, Samuel Q Li, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Scientific Reports|March 2, 2013
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interactionMarianeve Carotenuto, Emilia Pedone, Donatella Diana, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Pageof 14